3Gramlich TL, Fritsch CR, Maurer D, et al. Differential polymerase chain react i on assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pat hol, 1994,3:255-259.
4Kyomoto R, Kumazawa H, Toda Y, et al. Cyclin-D1-gene ampli fication is a more p otent prognostic factor than its protein over-expression in human head-and-ne ck squamous-cell carcinoma. Int J Cancer, 1997,74:576-581.
5Tlsty TD, Briot A, Gualberto A, et al. Genomic instability a nd cancer. Mutat Res, 1995, 337:1-7.
6Nakagawa H, Zukerberg L, Togawa K, et al. Human cyclin D1 on cogene and esophageal squamous cell carcinoma. Cancer, 1995,76:541-549.
7Kanavaros P,Stefanaki K,Valassiadou K,et al.Expression of p53,p21/waf,bcl-2,bax,Rb and Ki67 proteins in colorectal adenocarcinomas[J].Med Oncol,1999,16(1):23-30.
8Seo YH,Joo YE,Choi SK,et al.Prognostic significance of p53 and p21 expression in cancer[J].Korean J Intern Med,2003,18(2):98-103.
9Okuyama T,Maehara Y,Kabashima A,et al.Combined evaluation of expressions of p53 and p21 protein as prognostic factors for patients with gastric carcinoma[J].Oncology,2002,63(4):353-361.
10Liu XP,Kawauchi S,Oga A,et al.Combined examination of p27(KIP1),p21(Waf1/Cip1) and expression allows precise estimation of prognosis in patients with gastric carcinoma[J].Histopathology,2001,39(6):603-610.
